IL6 and neoplasm: The elevated levels of SASP by senescent T cells, such as IL-6, IL-8, and IL-18, promote tumor development and suppress antitumor immunity, regulating the tumor microenvironment through proinflammatory and anti-inflammatory cytokines [40].